,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,192,1,1,,442499,4138,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,248,1,1,,442499,4138,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,330,1,1,,442499,4138,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
3,422,1,5,,17405331,4138,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
4,429,1,5,,17405331,4138,Active,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
5,429,1,5,,17405331,4138,Active,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
6,436,2,1,,17405331,4138,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
7,547,1,4,,17405331,4138,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
8,694,1,1,,17405331,4138,Active,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
9,732,1,2,,17405331,4138,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
10,880,2,1,,50106598,4138,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
11,880,2,1,,50106598,4138,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
12,894,2,1,,50106598,4138,Active,31542939.0,3248.0,10.0,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
13,940,1,2,,17405331,4138,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
14,1030,2,1,,50106598,4138,Active,30582681.0,216.0,2.2387,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
15,1379,1,2,,50106598,4138,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
16,1422,1,1,,17405331,4138,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
17,1454,1,1,,50106598,4138,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
18,1457,1,1,,50106598,4138,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
19,1458,1,1,,50106598,4138,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
20,1459,1,1,,50106598,4138,Inactive,27436948.0,4000.0,,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
21,1460,1,3,,50106598,4138,Active,92096784.0,4137.0,3.9811,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
22,1461,1,2,,50106598,4138,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
23,1463,1,1,,50106598,4138,Inconclusive,,,3.1623,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
24,1467,1,3,,50106598,4138,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
25,1468,1,1,,50106598,4138,Inconclusive,92096784.0,4137.0,2.5119,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
26,1469,1,1,,50106598,4138,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
27,1476,2,1,,50106598,4138,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
28,1478,2,1,,50106598,4138,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
29,1479,1,2,,50106598,4138,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
30,1487,1,1,,50106598,4138,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
31,1519,1,3,,50106598,4138,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
32,1705,1,2,,50106598,4138,Inconclusive,6980812.0,,0.5623,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
33,1707,1,3,,50106598,4138,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
34,1708,1,3,,50106598,4138,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
35,1766,1,1,,50106598,4138,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
36,1766,1,1,,50106598,4138,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
37,1768,1,1,,50106598,4138,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
38,1768,1,1,,50106598,4138,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
39,1815,1,1,,50106598,4138,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
40,1816,1,1,,50106598,4138,Inconclusive,,,11.2202,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
41,1828,2,1,,50106598,4138,Inconclusive,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
42,1865,1,1,,50106598,4138,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
43,1876,1,1,,50106598,4138,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
44,1877,1,1,,50106598,4138,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
45,1882,1,1,,50106598,4138,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
46,1883,1,1,,50106598,4138,Inconclusive,,,10.0,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
47,1886,1,1,,50106598,4138,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
48,1948,1,1,,50106598,4138,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
49,1967,1,1,,85231121,4138,Inconclusive,4505907.0,5376.0,95.2834,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
50,2062,1,2,,85209727,4138,Active,,,,,Ligands of bioamine (Class A) GPCRs,Other,,
51,2101,1,1,,50106598,4138,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
52,2107,1,1,,50106598,4138,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
53,2112,1,1,,50106598,4138,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
54,2147,1,1,,50106598,4138,Active,221046486.0,,3.5481,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
55,2323,1,1,,50106598,4138,Inactive,254220970.0,,,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
56,2326,1,1,,50106598,4138,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
57,2353,1,3,,50106598,4138,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
58,2364,1,2,,50106598,4138,Inconclusive,4557365.0,641.0,25.1189,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
59,2451,1,2,,50106598,4138,Inconclusive,122920737.0,,11.1936,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
60,2517,2,1,,50106598,4138,Active,6980812.0,,1.122,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
61,2528,1,2,,50106598,4138,Inconclusive,4557365.0,641.0,25.1189,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
62,2549,1,1,,50106598,4138,Active,282403581.0,,3.1623,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
63,2660,1,1,,90340754,4138,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
64,2662,2,1,,85231121,4138,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
65,2666,1,1,,90340754,4138,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
66,2667,1,1,,90340754,4138,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
67,2668,1,1,,90340754,4138,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
68,2675,1,1,,50106598,4138,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
69,2732,1,1,,17405331,4138,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
70,2774,1,3,,92304210,4138,Inactive,,,,,LOPAC Circadian Assay,Screening,,
71,116921,6,2,,103195765,4138,Unspecified,,,,,Compound was tested for toxicity (lethal dose) in male white swiss mice,Other,7452683.0,
72,463096,1,1,,50106598,4138,Inactive,,,,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
73,463097,1,1,,50106598,4138,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
74,463106,1,2,,90340754,4138,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
75,463189,1,1,,53777876,4138,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
76,485290,1,1,,50106598,4138,Inconclusive,20150581.0,,0.631,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
77,485295,1,2,,90340754,4138,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
78,485297,1,1,,90340754,4138,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
79,485298,1,1,,90340754,4138,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
80,485313,1,2,,90340754,4138,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
81,485314,1,1,,50106598,4138,Active,4505931.0,5423.0,5.6234,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
82,485342,1,2,,90340754,4138,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
83,485345,1,2,,90340754,4138,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
84,485366,1,2,,90340754,4138,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
85,485368,1,2,,90340754,4138,Inconclusive,72386991.0,3656265.0,0.5358,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
86,488745,1,4,,85231121,4138,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
87,488752,1,4,,85231121,4138,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
88,488772,1,1,,90340754,4138,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
89,488773,1,2,,90340754,4138,Active,8659577.0,58819.0,2.9935,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
90,488816,1,1,,90340754,4138,Active,4758356.0,2237.0,2.3778,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
91,488837,1,1,,90340754,4138,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
92,488949,1,2,,85231121,4138,Active,41055989.0,54737.0,79.4328,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
93,488949,1,2,,90340754,4138,Active,41055989.0,54737.0,2.3778,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
94,488953,1,1,,90340754,4138,Active,187960037.0,10951.0,5.3233,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
95,488978,1,1,,90340754,4138,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
96,488979,1,1,,50106598,4138,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
97,488980,1,1,,85231121,4138,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
98,488981,1,1,,90340754,4138,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
99,488982,1,1,,90340754,4138,Inconclusive,4503383.0,1812.0,3.2641,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
100,488983,1,1,,90340754,4138,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
101,493106,1,1,,90340754,4138,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
102,493107,1,1,,90340754,4138,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
103,493127,1,1,,50106598,4138,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
104,493153,1,1,,90340754,4138,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
105,493153,1,1,,90340754,4138,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
106,493164,1,2,,90340754,4138,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
107,493164,1,2,,90340754,4138,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
108,493164,1,2,,90340754,4138,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
109,493189,1,1,,50106598,4138,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
110,504327,1,1,,90340754,4138,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
111,504332,1,1,,50106598,4138,Active,168985070.0,,0.7943,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
112,504332,1,1,,90340754,4138,Active,168985070.0,,0.9466,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
113,504364,1,1,,85231121,4138,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
114,504536,1,1,,90340754,4138,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
115,504547,1,1,,90340754,4138,Inconclusive,115503961.0,4357161.0,3.0131,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
116,504548,1,2,,90340754,4138,Inconclusive,157877932.0,5655980.0,30.1313,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
117,504810,1,2,,90340754,4138,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
118,504812,1,2,,90340754,4138,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
119,504821,1,1,,85231121,4138,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
120,504836,1,2,,90340754,4138,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
121,504845,1,1,,90340754,4138,Active,86301163.0,5999.0,10.6213,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
122,504847,1,1,,90340754,4138,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
123,504865,1,1,,90340754,4138,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
124,521220,3,3,,103195765,4138,Inactive,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
125,540256,1,2,,50106598,4138,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
126,540256,1,2,,90340754,4138,Inconclusive,,,3.5338,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
127,540276,1,2,,50106598,4138,Inconclusive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
128,540276,1,2,,50106599,4138,Inconclusive,420597.0,,6.2841,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
129,540276,1,2,,85231121,4138,Inconclusive,420597.0,,6.2841,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
130,540276,1,2,,90340754,4138,Inconclusive,420597.0,,6.2841,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
131,588349,1,1,,90340754,4138,Inconclusive,,,35.4813,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
132,588378,1,1,,90340754,4138,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
133,588453,1,1,,85231121,4138,Inconclusive,8659577.0,58819.0,18.8876,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
134,588453,1,1,,90340754,4138,Inconclusive,8659577.0,58819.0,2.9935,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
135,588456,1,1,,90340754,4138,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
136,588579,1,1,,90340754,4138,Inconclusive,7705344.0,51426.0,1.8888,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
137,588590,1,1,,50106598,4138,Inconclusive,154350220.0,11201.0,12.5893,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
138,588591,1,1,,50106598,4138,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
139,588795,1,1,,90340754,4138,Active,4758356.0,2237.0,2.3778,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
140,588834,2,1,,50106598,4138,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
141,602332,1,1,,90340754,4138,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
142,624146,1,1,,90340754,4138,Inactive,71051501.0,2744.0,11.2202,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
143,624147,1,1,,90340754,4138,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
144,624148,1,2,,90340754,4138,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
145,624149,1,1,,90340754,4138,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
146,624349,1,2,,121362411,4138,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
147,624455,1,1,,90340754,4138,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
148,651635,1,3,,90340754,4138,Inconclusive,171543895.0,6311.0,35.4813,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
149,651828,1,2,,121361626,4138,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
150,651828,1,2,,121362411,4138,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
151,652106,1,1,,90340754,4138,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
152,687035,1,1,,163564724,4138,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
153,687037,1,3,,163564724,4138,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
154,720532,1,1,,90340754,4138,Inactive,420597.0,,6.2841,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
155,720533,1,1,,90340754,4138,Inactive,,,3.5338,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
156,720538,1,2,,90340754,4138,Inactive,220983390.0,410.0,,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
157,720554,1,3,,121362411,4138,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
158,720559,1,2,,90340754,4138,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
159,720572,1,2,,90340754,4138,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
160,720573,1,2,,90340754,4138,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
161,743205,1,1,,90340754,4138,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
162,743205,1,1,,90340754,4138,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
163,743206,1,1,,90340754,4138,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
164,743206,1,1,,90340754,4138,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
165,743207,1,1,,90340754,4138,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
166,743207,1,1,,90340754,4138,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
167,743244,1,1,,90340754,4138,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
168,743268,1,1,,172080643,4138,Active,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
169,743270,1,1,,172080643,4138,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
170,743271,1,1,,172080643,4138,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
171,743272,1,1,,172080643,4138,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
172,781326,1,2,,103195765,4138,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X,Other,24249037.0,
173,1159580,2,1,,268738323,4138,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
174,1159580,2,1,,273002907,4138,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
175,1159607,2,1,,312310264,4138,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
176,1159620,1,1,,103195765,4138,Active,,,,,Summary of drug indications.,Other,,
177,1224818,1,1,,312344895,4138,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
178,1224819,1,1,,312344895,4138,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
179,1224820,1,1,,312344895,4138,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
180,1224821,1,1,,312344895,4138,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
181,1224822,1,1,,312344895,4138,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
182,1224823,1,1,,312344895,4138,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
183,1224857,2,1,,312344895,4138,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
184,1224859,2,1,,90340754,4138,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
185,1224905,2,1,,121361626,4138,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
186,1224905,2,1,,121361626,4138,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
187,1259310,1,1,,104170018,4138,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
188,1259310,1,1,,321942828,4138,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
189,1259310,1,1,,332949793,4138,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
190,1259310,1,1,,332950474,4138,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
191,1259325,1,2,,336956248,4138,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
192,1259354,1,1,,348422198,4138,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
193,1259370,2,2,,124749986,4138,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
194,1259370,2,2,,124749986,4138,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
195,1259370,2,2,,124749986,4138,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
196,1259406,1,1,,363920245,4138,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
197,1259406,1,1,1.0,363920245,4138,Inactive,26638650.0,3778.0,-0.0267728,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
198,1259406,1,1,2.0,363920245,4138,Inactive,4758626.0,3779.0,-0.07059839999999999,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
199,1259406,1,1,3.0,363920245,4138,Inactive,5031823.0,10242.0,-0.038112099999999996,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
200,1259406,1,1,4.0,363920245,4138,Inactive,26051275.0,27345.0,-0.00847135,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
201,1259406,1,1,5.0,363920245,4138,Inactive,160410009.0,389816.0,-0.0180587,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
202,1259406,1,1,6.0,363920245,4138,Inactive,26638650.0,3778.0,-0.031554900000000004,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
203,1259406,1,1,7.0,363920245,4138,Inactive,4758626.0,3779.0,-0.0726989,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
204,1259406,1,1,8.0,363920245,4138,Inactive,5031823.0,10242.0,-0.00349489,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
205,1259406,1,1,9.0,363920245,4138,Inactive,26051275.0,27345.0,-0.0805485,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
206,1259406,1,1,10.0,363920245,4138,Active,5031823.0,10242.0,-0.124548,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
207,1259413,1,2,,104170018,4138,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
208,1259423,1,2,,354792659,4138,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
209,1259423,1,2,,355021343,4138,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
